Blog
RSS FeedPosted by Michael Wonder on 29 Apr 2016
PBS and RPBS Section 85 date of processing and date of supply data
29 April 2016 - The PBS and RPBS Section 85 date of processing and date of supply data has now been ...
Posted by Michael Wonder on 28 Apr 2016
Big pharma gaming patents for extra cash: Productivity Commission
29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Australia, which is also slowing access ...
Posted by Michael Wonder on 28 Apr 2016
Anti-cancer drug Ribomustin added to PBS
28 April 2016 - Up to 30,000 Australians living with a slow-growing form of lymphoma could benefit from a new anti-cancer ...
Posted by Michael Wonder on 28 Apr 2016
Agenda for the July 2016 PBAC meeting
28 April 2016 - The agenda for the July 2016 PBAC meeting is now available. ...
Posted by Michael Wonder on 28 Apr 2016
PBAC to consider first submission for a cellular therapy in July
28 April 2016 - The PBAC will consider a major submission from Amgen for talimogene laherparepvec (Imlygic) at its next scheduled ...
Posted by Michael Wonder on 27 Apr 2016
bDMARDs on the PBS – are they all the same?
28 April 2016 - Adalimumab (Humira) has been listed on the Pharmaceutical Benefits Scheme (PBS) since 2004 for use by certain ...
Posted by Michael Wonder on 27 Apr 2016
NICE & PBAC outcomes differ for new heart failure drug Entresto
27 April 2016 - Around 100,000 people in England and Wales could now benefit from treatment with Novartis’ revolutionary heart failure ...
Posted by Michael Wonder on 27 Apr 2016
Medicines New Zealand has never threatened New Zealand
26 April 2016 - Recent statements in the media misrepresent the Medicines New Zealand position on the Trans-Pacific Partnership and are ...
Posted by Michael Wonder on 27 Apr 2016
NICE recommends ovarian cancer treatments
27 April 2016 - NICE has published final guidance for five ovarian cancer drugs. Three of the drugs are not recommended, ...
Posted by Michael Wonder on 26 Apr 2016
Call for patient input on a submission from Ferring Pharmaceuticals for budesonide
26 April 2016 - CADTH has received notice of a pending submission from Ferring Pharmaceuticals for budesonide for use by patients ...
Posted by Michael Wonder on 26 Apr 2016
TPP: no reason big pharma supply would stop
26 April 2016 - Trade Minister Todd McClay says he sees no reason why big pharmaceutical firms would stop supplying ...
Posted by Michael Wonder on 26 Apr 2016
How can a price be put on my daughter's life?'
27 April 2016 - A Sunshine Coast mother has failed in her attempt to have the Federal Government list on ...
Posted by Michael Wonder on 25 Apr 2016
Summary of submissions and outcomes from the March 2016 PBAC meeting
26 April 2016 - 69 submissions were considered at the March 2016 PBAC meeting. All bar one were prepared and lodged ...
Posted by Michael Wonder on 25 Apr 2016
Drug prices: tweaking the formula
25 April 2016 - UK regulators are under pressure from Big Pharma as well as patients. ...
Posted by Michael Wonder on 25 Apr 2016
Melanoma drug Keytruda denied full listing on PBS
26 April 2016 - A much-hyped melanoma drug credited with saving the life of businessman Ron Walker has been denied a ...